Cargando…
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews
BACKGROUND: Multiple published quantitative systematic reviews have reported on adverse events associated with the use of sodium glucose co-transporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus. AIMS: To summarize and appraise the quality of evidence from quantitative systemati...
Autores principales: | Pelletier, Ryan, Ng, Kelvin, Alkabbani, Wajd, Labib, Youssef, Mourad, Nicolas, Gamble, John-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844442/ https://www.ncbi.nlm.nih.gov/pubmed/33552467 http://dx.doi.org/10.1177/2042098621989134 |
Ejemplares similares
-
The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews
por: Pelletier, Ryan, et al.
Publicado: (2020) -
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
por: Alkabbani, Wajd, et al.
Publicado: (2021) -
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
por: Alkabbani, Wajd, et al.
Publicado: (2021) -
Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
por: Alkabbani, Wajd, et al.
Publicado: (2022) -
Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
por: Ng, William Hao Syuen, et al.
Publicado: (2022)